| Test | In Range | Out Of Range | Units | Reference |
|---|---|---|---|---|
| CBC | ||||
| White Blood Cell Count | 5.8 | K/uL | 4.0 - 11.0 | |
| Red Blood Cell Count | L 3.97 | M/uL | 4.40 - 6.00 | |
| Hemoglobin | L 12.7 | g/dL | 13.5 - 18.0 | |
| Hematocrit | L 39.4 | % | 40.0 - 52.0 | |
| MCV | 99 | fL | 80 - 100 | |
| MCH | 32.0 | pg | 27.0 - 33.0 | |
| MCHC | 32.2 | g/dL | 31.0 - 36.0 | |
| RDW | 13.1 | % | < 16.4 | |
| Platelet Count | 237 | K/uL | 150 - 400 | |
| Differential Type | Automated | |||
| Abs. Neutrophil | 4.2 | K/uL | 2.0 - 8.0 | |
| Abs. Lymphocyte | L 0.8 | K/uL | 1.0 - 5.1 | |
| Abs. Monocyte | 0.6 | K/uL | 0.0 - 0.8 | |
| Abs. Eosinophil | 0.1 | K/uL | 0.0 - 0.5 | |
| Abs. Basophil | 0.0 | K/uL | 0.0 - 0.2 | |
| Nucleated RBC Auto | 0.0 | /100 WBC | ||
| Comp Metabolic Panel | ||||
| Sodium | 139 | mmol/L | 136 - 145 | |
| Potassium | 4.3 | mmol/L | 3.5 - 5.1 | |
| Chloride | 105 | mmol/L | 98 - 107 | |
| CO2 (Bicarbonate) | 28 | mmol/L | 21 - 32 | |
| Anion Gap | 6 | mmol/L | 3 - 12 | |
| Glucose | 83 | mg/dL | 70 - 99 | |
| BUN | 23 H | mg/dL | 7 - 18.0 | |
| Creatinine | 1.26 | mg/dL | 0.50 - 1.30 | |
| GFR Est-Other | L 55 | > 60 | ||
| Units: mL/min/1.73 m2. Estimated glomerular filtration rate values are calculated using the CKD-EPI equation. | ||||
| Calcium | 9.3 | mg/dL | 8.5 - 10.1 | |
| Total Protein | 6.5 | g/dL | 6.2 - 8.5 | |
| Albumin | 3.8 | g/dL | 3.4 - 5.0 | |
| Total Bilirubin | 0.4 | mg/dL | < 1.1 | |
| Alkaline Phosphatase | 85 | U/L | 50 - 136 | |
| AST | 18 | U/L | 15 - 37 | |
| ALT | 25 | U/L | 0 - 60 | |
| Vitamin B12 Level | 563 | pg/mL | 211 - 911 | |
| Vitamin B6 | 17.0 | ng/mL | 2.1 - 21.7 | |
| Vitamin supplementation within 24 hours prior to blood draw may affect the accuracy of results. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | ||||
| Vitamin B1, Blood | 151 | nmol/L | 78 - 185 | |
| Vitamin supplementation within 24 hours prior to blood draw may affect the accuracy of results. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | ||||
| Vitamin D, 25-Hydroxy Tot | 129 H | ng/mL | 30 - 100 | |
| This Total 35-OHD assay measures the sum of 25-hydroxy (D2 and D3) vitamin D metabgoliters. Therapy indications are gbased on Total 25-OHD. | ||||
| Ferritin (Iron Test) | 44 | ng/mL | 20 - 388 | |
| Iron | 96 | ug/dL | 35 - 150 | |
| Iron Binding | 293 | ug/dL | 250 - 450 | |
| Iron % Saturation | 33 | % | 20 - 50 | |
| PSA, Total | 3.17 | ng/mL | < 4 | |
| Results obtained using Dade Behring EIA method. Numeric values obtained from other manufacturer's methods may not be used interchangeably. | ||||
| Zinc | 68 | ug/dL | 60 - 130 | |
| This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | ||||
| Doctor's File Notes | History | Lab Test Results |
| Medication | Symptoms | Table of Contents |